University of Vienna, Faculty of Life Sciences, Division of Pharmaceutical Technology and Biopharmaceutics, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.
University of Vienna, Faculty of Life Sciences, Division of Pharmaceutical Technology and Biopharmaceutics, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.
Nanomedicine. 2023 Jun;50:102685. doi: 10.1016/j.nano.2023.102685. Epub 2023 Apr 25.
Urinary tract infections (UTIs) are among the most common bacterial infections. Despite a wide range of therapeutic options, treatment success is compromised by the efficient mechanism of tissue colonization of uropathogenic Escherichia coli. In advanced drug delivery systems, a similar, glycan-mediated targeting mechanism may be realized by conjugating the drug to a plant lectin, like wheat germ agglutinin (WGA). We introduce a drug delivery vehicle consisting of human serum albumin as nanoparticle shell, olive oil as core component, the active pharmaceutical ingredients (API) trimethoprim and rifampicin as well as WGA to facilitate cellular internalization. When WGA was embedded into the proteinaceous particle shell, cell binding studies revealed up to 60 % higher cell binding potential. Additionally, nanoparticles showed a good efficacy against gram-negative just as against gram-positive bacteria. The combination of the promising cell-associative properties and the proven antimicrobial potential might lead to an improved efficacy of advanced treatment of UTIs.
尿路感染(UTIs)是最常见的细菌性感染之一。尽管有广泛的治疗选择,但由于尿路致病性大肠杆菌在组织中的定植效率很高,治疗效果仍受到影响。在先进的药物输送系统中,可以通过将药物与植物凝集素(如麦胚凝集素(WGA))缀合来实现类似的、糖介导的靶向机制。我们引入了一种药物输送载体,由人血清白蛋白作为纳米颗粒壳、橄榄油作为核心成分、活性药物成分(API)甲氧苄啶和利福平以及 WGA 组成,以促进细胞内化。当 WGA 嵌入蛋白质颗粒壳中时,细胞结合研究显示出高达 60%的更高细胞结合潜力。此外,纳米颗粒对革兰氏阴性菌和革兰氏阳性菌均显示出良好的疗效。有希望的细胞关联特性与已证明的抗菌潜力相结合,可能会提高治疗尿路感染的先进治疗方法的疗效。